14 Aug Cannabis, Pregnancy and Breastfeeding: What Mothers Should Know
Cannabis, Pregnancy and Breastfeeding: The Conversation Mothers Deserve
Pregnancy comes with plenty of unsolicited advice. Everybody suddenly has an opinion about what a mother should eat, drink, take, avoid, think and apparently even Google.
But when the subject is cannabis, honest medical conversation is too often replaced by stigma.
Some mothers report using cannabis to manage severe nausea, appetite loss, pain, anxiety or insomnia during pregnancy. That does not automatically mean cannabis is safe, but it does mean these women deserve accurate information—not judgment, punishment or exaggerated scare tactics.
Suncoast NORML recently took a deeper look at cannabis, pregnancy, breastfeeding and the science of the human endocannabinoid system. The findings raise important questions about how we discuss cannabis compared with conventional medications.
Read the full Suncoast NORML article here
Yes, Human Breast Milk Naturally Contains Endocannabinoids
One of the most fascinating facts in this debate is that human breast milk naturally contains endocannabinoids.
Researchers have identified anandamide, also known as AEA, and 2-arachidonoylglycerol, or 2-AG, in human milk. These are signaling molecules produced by the body that interact with cannabinoid receptors and may be involved in appetite, metabolism, nervous-system development and the infant suckling response.
In other words, breastfeeding already involves the transfer of naturally produced cannabinoid compounds.
That does not make anandamide and THC interchangeable. THC is a plant-derived cannabinoid with different properties, and it can remain in breast milk for days or even weeks. The presence of anandamide does not prove that using cannabis while breastfeeding is safe.
What it does prove is that cannabinoid signaling is already a natural part of human biology—and that the conversation deserves more scientific depth than “cannabis bad.”
What Did the Jamaican Cannabis Study Find?
The new Suncoast NORML article also examines a frequently cited study involving mothers and children in rural Jamaica.
Researchers compared children whose mothers used cannabis during pregnancy with children whose mothers did not. The original neonatal research found no significant developmental problems associated with prenatal exposure during the first days of life. At one month, the cannabis-exposed newborns actually received better scores on several measurements, including alertness, irritability, autonomic stability and self-regulation.
A follow-up tracked 59 children through age five. Researchers found no significant developmental differences attributable to prenatal cannabis exposure. The quality of the child’s home environment appeared to be more influential than the mother’s reported cannabis use.
That does not prove cannabis is harmless during pregnancy. The sample was small, the study was observational and the cannabis involved may not resemble today’s high-potency products.
Still, these results challenge the idea that prenatal cannabis exposure inevitably causes serious developmental damage.
What About Prescription Medications?
Cannabis is frequently portrayed as uniquely dangerous while potentially addictive pharmaceutical drugs receive a very different public response.
Pregnant patients may be prescribed opioids, benzodiazepines, antidepressants, sleep medications and other drugs when a doctor believes their benefits outweigh their risks. Some of these medications are medically necessary, and nobody should stop a prescription without speaking with a healthcare professional.
However, legal does not mean harmless.
Prolonged opioid exposure during pregnancy can cause neonatal opioid withdrawal syndrome. Other medication combinations have also been associated with an increased risk of newborn withdrawal.
This does not prove cannabis is safer than every prescription drug. It does show why mothers deserve honest comparisons based on evidence—not assumptions based solely on which substance came from a pharmacy.
Watch the Conversation on The Rotation
This topic was also discussed on The Rotation by Suncoast NORML. The podcast clip explores the endocannabinoid system, cannabinoids in breast milk, maternal cannabis use and the contradictions surrounding how society treats cannabis during pregnancy.
Watch the clip above for the conversation, then visit Suncoast NORML for the complete research breakdown, study links, limitations and current medical guidance.
Click here to read the complete Suncoast NORML investigation
Mothers Need Information, Not Stigma
Current medical organizations generally recommend avoiding cannabis during pregnancy and breastfeeding because researchers have not established a safe dose. THC can cross the placenta and enter breast milk, and long-term evidence remains incomplete.
But incomplete evidence should lead to better research—not automatic criminalization or shame.
Mothers should be able to discuss cannabis use honestly with their healthcare providers. They should receive individualized information about potential benefits, risks, product potency, frequency of use and available alternatives.
Most importantly, they should not avoid prenatal care because they fear being judged or punished.
The endocannabinoid system is real. Anandamide in breast milk is real. The Jamaican findings are real. The remaining uncertainty is also real.
That is exactly why this conversation matters.
Read the full article from Suncoast NORML:
Cannabis, Pregnancy and Breastfeeding: What Mothers Deserve to Know
This article is provided for educational purposes and is not medical advice. Anyone who is pregnant, breastfeeding or planning a pregnancy should consult a qualified healthcare professional before using cannabis, changing medications or discontinuing prescribed treatment.
No Comments